Company intelligence / Profile preview
Genue
Seoul, South Korea
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Genuv is a clinical-stage biotechnology company based in South Korea, specializing in the discovery and development of innovative therapeutics for neurodegenerative diseases and immuno-oncology. The company utilizes its proprietary ATRIVIEW platform for phenotypic screening to identify neuroprotective and neuroregenerative drug candidates, and its SHINE MOUSE platform for the discovery of high-affinity monoclonal antibodies. Genuv's lead program, SNR1611 (trametinib), is currently being evaluated in Phase 1/2a clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) and Alzheimer's disease. Additionally, the company is advancing a pipeline of antibody-based therapies, including GNUV201, a novel anti-PD-1 antibody designed for enhanced selectivity in the tumor microenvironment.
- Therapeutic areas
- NeurologyOncology
- Modalities
- Small moleculeMonoclonal antibodyBiologicRecombinant fusion proteinPeptides
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Genue.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genue.